Issue 6, 2023

Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer

Abstract

Aberrant translation of proteins that promote cell proliferation is an essential factor that defines oncogenic processes and cancer. The process for ribosomal translation of proteins from mRNA requires an essential initiation step which is controlled by the protein eIF4E, which binds the RNA 5′-cap and forms the eIF4F complex that subsequently translates protein. Typically, eIF4E is activated by phosphorylation on Ser209 by MNK1 and MNK2 kinases. Substantial work has shown that eIF4E and MNK1/2 are dysregulated in many cancers and this axis has therefore become an active area of interest for developing new cancer therapeutics. This review summarizes and discusses recent work to develop small molecules that target different steps in the MNK–eIF4E axis as potential cancer therapeutics. The aim of this review is to cover the breadth of different molecular approaches being taken and the medicinal chemistry basis for their optimization and testing as new cancer therapeutics.

Graphical abstract: Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer

Article information

Article type
Review Article
Submitted
15 mar 2023
Accepted
08 may 2023
First published
09 may 2023

RSC Med. Chem., 2023,14, 1060-1087

Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer

A. Fernandez, P. J. Monsen, L. C. Platanias and G. E. Schiltz, RSC Med. Chem., 2023, 14, 1060 DOI: 10.1039/D3MD00121K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements